This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig v2.0 was used to generate the results found in this report.
Working with individual set: LAML.
Number of patients in set: 199
The input for this pipeline is a set of individuals with the following files associated for each:
1. An annotated .maf file describing the mutations called for the respective individual, and their properties.
2. A .wig file that contains information about the coverage of the sample.
Significantly mutated genes (q ≤ 0.1): 68
Mutations seen in COSMIC: 234
Significantly mutated genes in COSMIC territory: 18
Genes with clustered mutations (&le 3 aa apart): 32
Significantly mutated genesets: 71
Significantly mutated genesets: (excluding sig. mutated genes): 1
type | count |
---|---|
Frame_Shift_Del | 103 |
Frame_Shift_Ins | 119 |
In_Frame_Del | 100 |
In_Frame_Ins | 59 |
Missense_Mutation | 2725 |
Nonsense_Mutation | 191 |
Nonstop_Mutation | 2 |
Silent | 1072 |
Splice_Site | 105 |
Total | 4476 |
category | n | N | rate | rate_per_mb | relative_rate |
---|---|---|---|---|---|
*CpG->T | 801 | 275075312 | 2.9e-06 | 2.9 | 4.7 |
*Cp(A/C/T)->T | 690 | 2493147819 | 2.8e-07 | 0.28 | 0.45 |
A->G | 365 | 2773129874 | 1.3e-07 | 0.13 | 0.21 |
transver | 869 | 5541353005 | 1.6e-07 | 0.16 | 0.26 |
indel+null | 670 | 5541353204 | 1.2e-07 | 0.12 | 0.2 |
double_null | 9 | 5541353204 | 1.6e-09 | 0.0016 | 0.0026 |
Total | 3404 | 5541353204 | 6.1e-07 | 0.61 | 1 |
The x axis represents the samples. The y axis represents the exons, one row per exon, and they are sorted by average coverage across samples. For exons with exactly the same average coverage, they are sorted next by the %GC of the exon. (The secondary sort is especially useful for the zero-coverage exons at the bottom).
rank | gene | description | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p_classic | p_ks | p_cons | p_joint | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 254123 | 20 | 20 | 2 | 0 | 18 | 0 | 0 | 2 | 0 | 0 | <1.00e-15 | 2e-07 | 0.97 | 0.000011 | <0.00 | <0.00 |
2 | U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 154822 | 10 | 10 | 3 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | <1.00e-15 | 0.000026 | 0.0093 | 0.000014 | <0.00 | <0.00 |
3 | TET2 | tet oncogene family member 2 | 696898 | 17 | 15 | 17 | 0 | 0 | 1 | 0 | 2 | 9 | 5 | <1.00e-15 | 1 | 0.0015 | 0.006 | <2.22e-16 | <9.59e-13 |
4 | KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 140693 | 9 | 9 | 5 | 0 | 0 | 4 | 1 | 4 | 0 | 0 | <1.00e-15 | 0.0048 | 0.2 | 0.0052 | <2.22e-16 | <9.59e-13 |
5 | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 146663 | 19 | 17 | 16 | 0 | 1 | 3 | 2 | 3 | 9 | 1 | <1.00e-15 | 0.015 | 0.12 | 0.015 | <5.55e-16 | <1.44e-12 |
6 | WT1 | Wilms tumor 1 | 166364 | 13 | 13 | 9 | 0 | 1 | 1 | 0 | 0 | 10 | 1 | <1.00e-15 | 0.0086 | 1 | 0.019 | <7.77e-16 | <1.44e-12 |
7 | FLT3 | fms-related tyrosine kinase 3 | 603169 | 53 | 52 | 29 | 0 | 0 | 1 | 1 | 16 | 35 | 0 | 3.00e-15 | 2e-07 | 2e-07 | 0 | <1.00e-15 | <1.44e-12 |
8 | DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 517997 | 55 | 50 | 28 | 0 | 33 | 2 | 2 | 4 | 14 | 0 | <1.00e-15 | 2e-07 | 2e-07 | 0 | <1.00e-15 | <1.44e-12 |
9 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 185269 | 47 | 47 | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | <1.00e-15 | 2e-07 | 2e-07 | 0 | <1.00e-15 | <1.44e-12 |
10 | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 232631 | 20 | 20 | 2 | 0 | 16 | 3 | 0 | 1 | 0 | 0 | 2.55e-15 | 2e-07 | 0.62 | 0 | <1.00e-15 | <1.44e-12 |
11 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 116614 | 18 | 18 | 6 | 0 | 0 | 9 | 1 | 8 | 0 | 0 | 2.22e-15 | 2e-07 | 0.13 | 0 | <1.00e-15 | <1.44e-12 |
12 | OR5H6 | olfactory receptor, family 5, subfamily H, member 6 | 195418 | 4 | 4 | 1 | 2 | 0 | 0 | 0 | 0 | 4 | 0 | 3.16e-08 | 4e-07 | 0.034 | 0 | <1.00e-15 | <1.44e-12 |
13 | TP53 | tumor protein p53 | 260889 | 15 | 11 | 15 | 1 | 3 | 2 | 4 | 1 | 5 | 0 | 2.00e-15 | 0.0074 | 0.18 | 0.02 | 1.55e-15 | 2.07e-12 |
14 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 591229 | 8 | 7 | 5 | 0 | 1 | 0 | 0 | 5 | 2 | 0 | 1.57e-11 | 0.011 | 0.024 | 0.0079 | 3.83e-12 | 4.72e-09 |
15 | AP3S1 | adaptor-related protein complex 3, sigma 1 subunit | 106067 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 3.98e-07 | 2.8e-06 | 0.12 | 8e-07 | 9.48e-12 | 1.08e-08 |
16 | PHF6 | PHD finger protein 6 | 246561 | 6 | 6 | 6 | 0 | 0 | 1 | 0 | 1 | 4 | 0 | 1.97e-12 | 0.47 | 0.067 | 0.17 | 9.98e-12 | 1.08e-08 |
17 | SCRN3 | secernin 3 | 259297 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 5.78e-07 | 8e-07 | 0.93 | 1.4e-06 | 2.33e-11 | 2.37e-08 |
18 | MPRIP | 375911 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 5.36e-06 | 2e-07 | 1 | 2e-07 | 3.06e-11 | 2.94e-08 | |
19 | CYP21A2 | cytochrome P450, family 21, subfamily A, polypeptide 2 | 205567 | 4 | 4 | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 3.65e-06 | 4e-07 | 1 | 5.8e-06 | 5.41e-10 | 4.92e-07 |
20 | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) | 362976 | 7 | 7 | 6 | 0 | 0 | 3 | 1 | 3 | 0 | 0 | 5.42e-10 | 0.075 | 0.13 | 0.077 | 1.04e-09 | 8.95e-07 |
21 | ETV6 | ets variant gene 6 (TEL oncogene) | 276809 | 5 | 5 | 5 | 0 | 0 | 0 | 1 | 1 | 3 | 0 | 1.06e-09 | 0.083 | 0.067 | 0.049 | 1.28e-09 | 1.05e-06 |
22 | NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 380488 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 5.28e-06 | 0.000034 | 0.71 | 0.000034 | 4.21e-09 | 3.30e-06 |
23 | LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 268252 | 3 | 3 | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0.000061 | 1.2e-06 | 0.71 | 4.6e-06 | 6.44e-09 | 4.83e-06 |
24 | C17orf97 | 168553 | 5 | 5 | 4 | 1 | 0 | 0 | 1 | 4 | 0 | 0 | 1.12e-08 | 0.22 | 0.99 | 0.47 | 1.05e-07 | 0.000075 | |
25 | ZNF626 | zinc finger protein 626 | 326559 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00039 | 0.0006 | 0.00048 | 2e-05 | 1.55e-07 | 0.00011 |
26 | MUC4 | mucin 4, cell surface associated | 1002562 | 10 | 7 | 8 | 6 | 1 | 0 | 1 | 5 | 3 | 0 | 2.21e-08 | 0.99 | 0.87 | 1 | 4.11e-07 | 0.00027 |
27 | SMC3 | structural maintenance of chromosomes 3 | 746449 | 6 | 6 | 6 | 0 | 1 | 1 | 1 | 1 | 2 | 0 | 3.18e-08 | 0.79 | 0.29 | 0.83 | 4.89e-07 | 0.00031 |
28 | ARSD | arylsulfatase D | 356608 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0.011 | 0.00073 | 0.000078 | 3e-06 | 6.10e-07 | 0.00038 |
29 | NOTCH2NL | Notch homolog 2 (Drosophila) N-terminal like | 144673 | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 1.33e-06 | NaN | NaN | NaN | 1.33e-06 | 0.00079 |
30 | C16orf71 | chromosome 16 open reading frame 71 | 278600 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.0013 | 0.00071 | 0.001 | 0.00012 | 2.64e-06 | 0.0015 |
31 | SKA3 | 241785 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00026 | 0.00082 | 0.37 | 0.00071 | 3.01e-06 | 0.0017 | |
32 | PRSS16 | protease, serine, 16 (thymus) | 290142 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00015 | 0.00068 | 0.65 | 0.0012 | 3.11e-06 | 0.0017 |
33 | CCDC144B | coiled-coil domain containing 144B | 212930 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.000087 | 0.00091 | 0.33 | 0.0035 | 4.84e-06 | 0.0025 |
34 | ACTRT2 | actin-related protein T2 | 188851 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00032 | 0.0011 | 0.51 | 0.0011 | 5.34e-06 | 0.0027 |
35 | RAD21 | RAD21 homolog (S. pombe) | 387652 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 1.02e-06 | 0.79 | 0.098 | 0.56 | 8.71e-06 | 0.0043 |
Note:
N - number of sequenced bases in this gene across the individual set.
n - number of (nonsilent) mutations in this gene across the individual set.
npat - number of patients (individuals) with at least one nonsilent mutation.
nsite - number of unique sites having a non-silent mutation.
nsil - number of silent mutations in this gene across the individual set.
n1 - number of nonsilent mutations of type: *CpG->T .
n2 - number of nonsilent mutations of type: *Cp(A/C/T)->T .
n3 - number of nonsilent mutations of type: A->G .
n4 - number of nonsilent mutations of type: transver .
n5 - number of nonsilent mutations of type: indel+null .
null - mutation category that includes nonsense, frameshift, splice-site mutations
p_classic = p-value for the observed amount of nonsilent mutations being elevated in this gene
p_ns_s = p-value for the observed nonsilent/silent ratio being elevated in this gene
p = p-value (overall)
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
In this analysis, COSMIC is used as a filter to increase power by restricting the territory of each gene. Cosmic version: v48.
rank | gene | description | n | cos | n_cos | N_cos | cos_ev | p | q |
---|---|---|---|---|---|---|---|---|---|
1 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 20 | 3 | 20 | 597 | 29840 | 0 | 0 |
2 | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 20 | 6 | 20 | 1194 | 2000 | 0 | 0 |
3 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 47 | 29 | 47 | 5771 | 172819 | 0 | 0 |
4 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 18 | 28 | 18 | 5572 | 13364 | 0 | 0 |
5 | FLT3 | fms-related tyrosine kinase 3 | 53 | 114 | 49 | 22686 | 6227 | 0 | 0 |
6 | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) | 7 | 31 | 6 | 6169 | 260 | 0 | 0 |
7 | KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 9 | 51 | 8 | 10149 | 62973 | 0 | 0 |
8 | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 19 | 175 | 17 | 34825 | 88 | 0 | 0 |
9 | WT1 | Wilms tumor 1 | 13 | 185 | 11 | 36815 | 563 | 0 | 0 |
10 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 8 | 183 | 7 | 36417 | 3934 | 0 | 0 |
Note:
n - number of (nonsilent) mutations in this gene across the individual set.
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos.
N_cos = number of individuals times cos.
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene.
p = p-value for seeing the observed amount of overlap in this gene)
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
num | gene | desc | n | mindist | nmuts0 | nmuts3 | nmuts12 | npairs0 | npairs3 | npairs12 |
---|---|---|---|---|---|---|---|---|---|---|
659 | DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 55 | 0 | 380 | 382 | 398 | 380 | 382 | 398 |
1037 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 20 | 0 | 190 | 190 | 190 | 190 | 190 | 190 |
1038 | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 20 | 0 | 139 | 139 | 139 | 139 | 139 | 139 |
836 | FLT3 | fms-related tyrosine kinase 3 | 53 | 0 | 120 | 120 | 136 | 120 | 120 | 136 |
1487 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 18 | 0 | 45 | 81 | 81 | 45 | 81 | 81 |
1916 | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 19 | 0 | 12 | 16 | 20 | 12 | 16 | 20 |
1155 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 8 | 0 | 10 | 10 | 10 | 10 | 10 | 10 |
1169 | KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 9 | 0 | 7 | 15 | 15 | 7 | 15 | 15 |
1212 | LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 3 | 0 | 3 | 3 | 3 | 3 | 3 | 3 |
1788 | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) | 7 | 0 | 1 | 2 | 7 | 1 | 2 | 7 |
Note:
n - number of mutations in this gene in the individual set.
mindist - distance (in aa) between closest pair of mutations in this gene
npairs3 - how many pairs of mutations are within 3 aa of each other.
npairs12 - how many pairs of mutations are within 12 aa of each other.
rank | geneset | description | genes | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | Genes involved in cytokine-cytokine receptor interaction | ACVR1, ACVR1B, ACVR2A, ACVR2B, AMH, AMHR2, BMP2, BMP7, BMPR1A, BMPR1B, BMPR2, CCL1, CCL11, CCL13, CCL14, CCL15, CCL16, CCL17, CCL18, CCL19, CCL2, CCL20, CCL21, CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CCL28, CCL3, CCL4, CCL5, CCL7, CCL8, CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9, CD27, CD40, CD40LG, CD70, CLCF1, CNTF, CNTFR, CRLF2, CSF1, CSF1R, CSF2, CSF2RA, CSF2RB, CSF3, CSF3R, CTF1, CX3CL1, CX3CR1, CXCL1, CXCL10, CXCL11, CXCL12, CXCL13, CXCL14, CXCL16, CXCL2, CXCL3, CXCL5, CXCL6, CXCL9, CXCR3, CXCR4, CXCR6, EDA, EDA2R, EDAR, EGF, EGFR, EPO, EPOR, FAS, FASLG, FLJ78302, FLT1, FLT3, FLT3LG, FLT4, GDF5, GH1, GH2, GHR, HGF, IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNAR1, IFNAR2, IFNB1, IFNE1, IFNG, IFNGR1, IFNGR2, IFNK, IFNW1, IL10, IL10RA, IL10RB, IL11, IL11RA, IL12A, IL12B, IL12RB1, IL12RB2, IL13, IL13RA1, IL15, IL15RA, IL17A, IL17B, IL17RA, IL17RB, IL18, IL18R1, IL18RAP, IL19, IL1A, IL1B, IL1R1, IL1R2, IL1RAP, IL2, IL20, IL20RA, IL21, IL21R, IL22, IL22RA1, IL22RA2, IL23A, IL23R, IL24, IL25, IL26, IL28A, IL28B, IL28RA, IL29, IL2RA, IL2RB, IL2RG, IL3, IL3RA, IL4, IL4R, IL5, IL5RA, IL6, IL6R, IL6ST, IL7, IL7R, IL8, IL8RA, IL8RB, IL9, IL9R, INHBA, INHBB, INHBC, INHBE, KDR, KIT, KITLG, LEP, LEPR, LIF, LIFR, LOC728045, LTA, LTB, LTBR, MET, MPL, NGFR, OSM, OSMR, PDGFB, PDGFC, PDGFRA, PDGFRB, PF4, PF4V1, PLEKHO2, PPBP, PRL, PRLR, RELT, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TNF, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11A, TNFRSF11B, TNFRSF12A, TNFRSF13B, TNFRSF13C, TNFRSF14, TNFRSF17, TNFRSF18, TNFRSF19, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFRSF4, TNFRSF6B, TNFRSF8, TNFRSF9, TNFSF10, TNFSF11, TNFSF12, TNFSF13, TNFSF13B, TNFSF14, TNFSF15, TNFSF18, TNFSF4, TNFSF8, TNFSF9, TPO, TSLP, VEGFA, VEGFB, VEGFC, XCL1, XCL2, XCR1 | 242 | ACVR2B(1), CCL11(1), CCL16(1), CCL17(1), CCL20(1), CCL21(1), CD70(1), CLCF1(1), CSF3R(2), CXCL16(1), EGF(1), EGFR(2), FLT1(1), FLT3(53), GHR(1), IFNA16(1), IL1R1(1), IL23R(1), IL25(1), KDR(2), KIT(8), KITLG(1), MPL(1), PDGFRA(1), PDGFRB(1), PLEKHO2(1), TPO(1) | 50091285 | 89 | 80 | 62 | 10 | 7 | 10 | 3 | 31 | 38 | 0 | <1.00e-15 | <3.85e-14 |
2 | HSA04640_HEMATOPOIETIC_CELL_LINEAGE | Genes involved in hematopoietic cell lineage | ANPEP, CD14, CD19, CD1A, CD1B, CD1C, CD1D, CD1E, CD2, CD22, CD24, CD33, CD34, CD36, CD37, CD38, CD3D, CD3E, CD3G, CD4, CD44, CD5, CD55, CD59, CD7, CD8A, CD8B, CD9, CR1, CR2, CSF1, CSF1R, CSF2, CSF2RA, CSF3, CSF3R, DNTT, EPO, EPOR, FCER2, FCGR1A, FLT3, FLT3LG, GP1BA, GP1BB, GP5, GP9, GYPA, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, IL11, IL11RA, IL1A, IL1B, IL1R1, IL1R2, IL2RA, IL3, IL3RA, IL4, IL4R, IL5, IL5RA, IL6, IL6R, IL7, IL7R, IL9R, ITGA1, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGAM, ITGB3, KIT, KITLG, MME, MS4A1, TFRC, THPO, TNF, TPO | 83 | CR1(1), CSF3R(2), FLT3(53), IL1R1(1), ITGA4(1), KIT(8), KITLG(1), MS4A1(1), TPO(1) | 24232827 | 69 | 66 | 42 | 3 | 3 | 3 | 1 | 24 | 38 | 0 | <1.00e-15 | <3.85e-14 |
3 | HSA00271_METHIONINE_METABOLISM | Genes involved in methionine metabolism | AHCY, AMD1, BHMT, CBS, CTH, DNMT1, DNMT3A, DNMT3B, KIAA0828, MARS, MARS2, MAT1A, MAT2B, MTAP, MTFMT, MTR, SRM, TAT | 17 | CBS(1), DNMT1(2), DNMT3A(55), DNMT3B(2), MAT1A(1) | 5761050 | 61 | 54 | 34 | 0 | 35 | 2 | 4 | 6 | 14 | 0 | <1.00e-15 | <3.85e-14 |
4 | METHIONINE_METABOLISM | AHCY, BHMT, CBS, CTH, DNMT1, DNMT2, DNMT3A, DNMT3B, MARS, MARS2, MAT1A, MAT2B, MTR | 12 | CBS(1), DNMT1(2), DNMT3A(55), DNMT3B(2), MAT1A(1) | 4890226 | 61 | 54 | 34 | 0 | 35 | 2 | 4 | 6 | 14 | 0 | <1.00e-15 | <3.85e-14 | |
5 | ERYTHPATHWAY | Erythropoietin selectively stimulates erythrocyte differentiation from CFU-GEMM cells in bone marrow. | CCL3, CSF2, CSF3, EPO, FLT3, IGF1, IL11, IL1A, IL3, IL6, IL9, KITLG, TGFB1, TGFB2, TGFB3 | 14 | FLT3(53), KITLG(1) | 2401930 | 54 | 53 | 30 | 0 | 0 | 1 | 1 | 17 | 35 | 0 | <1.00e-15 | <3.85e-14 |
6 | HSA04530_TIGHT_JUNCTION | Genes involved in tight junction | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, AMOTL1, ASH1L, CASK, CDC42, CDK4, CGN, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CRB3, CSDA, CSNK2A1, CSNK2A2, CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTTN, EPB41, EPB41L1, EPB41L2, EPB41L3, EXOC3, EXOC4, F11R, GNAI1, GNAI2, GNAI3, HCLS1, HRAS, IGSF5, INADL, JAM2, JAM3, KRAS, LLGL1, LLGL2, MAGI1, MAGI2, MAGI3, MLLT4, MPDZ, MPP5, MRAS, MRCL3, MRLC2, MYH1, MYH10, MYH11, MYH13, MYH14, MYH15, MYH2, MYH3, MYH4, MYH6, MYH7, MYH7B, MYH8, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NRAS, OCLN, PARD3, PARD6A, PARD6B, PARD6G, PPM1J, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R3A, PPP2R3B, PPP2R4, PRKCA, PRKCB1, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAB13, RAB3B, RHOA, RRAS, RRAS2, SPTAN1, SRC, SYMPK, TJAP1, TJP1, TJP2, TJP3, VAPA, YES1, ZAK | 126 | CDC42(1), CGN(1), CLDN11(1), CLDN16(1), CLDN18(1), CTNNA2(1), EXOC4(1), GNAI2(1), HCLS1(1), IGSF5(1), JAM2(1), KRAS(9), LLGL2(1), MAGI1(1), MAGI2(1), MAGI3(1), MLLT4(2), MYH1(1), MYH13(2), MYH14(1), MYH15(1), MYH6(2), MYH7(2), MYL9(1), NRAS(18), PARD3(1), PPP2R1B(1), PPP2R2B(1), PPP2R3A(1), PRKCG(1), TJAP1(3), TJP1(1), TJP2(1) | 55248171 | 64 | 51 | 47 | 13 | 12 | 19 | 6 | 22 | 5 | 0 | <1.00e-15 | <3.85e-14 |
7 | NUCLEAR_RECEPTORS | ALK, AR, ESR1, ESR2, ESRRA, HNF4A, NPM1, NR0B1, NR1D2, NR1H2, NR1H3, NR1I2, NR1I3, NR2C2, NR2E1, NR2F1, NR2F2, NR2F6, NR3C1, NR4A1, NR4A2, NR5A1, NR5A2, PGR, PPARA, PPARD, PPARG, RARA, RARB, RARG, ROR1, RORA, RORC, RXRA, RXRB, RXRG, THRA, THRA, NR1D1, THRB, VDR | 38 | NPM1(47), NR1D1(1), NR1D2(1), NR2E1(2), THRA(1), THRB(1) | 11707369 | 53 | 51 | 7 | 1 | 1 | 2 | 0 | 2 | 48 | 0 | <1.00e-15 | <3.85e-14 | |
8 | HSA04650_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | Genes involved in natural killer cell mediated cytotoxicity | ARAF, BID, BRAF, CASP3, CD244, CD247, CD48, CHP, CSF2, FAS, FASLG, FCER1G, FCGR3A, FCGR3B, FYN, GRB2, GZMB, HCST, HLA-A, HLA-B, HLA-C, HLA-E, HLA-G, HRAS, ICAM1, ICAM2, IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNAR1, IFNAR2, IFNB1, IFNG, IFNGR1, IFNGR2, ITGAL, ITGB2, KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR2DL5A, KIR2DS1, KIR2DS2, KIR3DL1, KIR3DL2, KLRC1, KLRC2, KLRC3, KLRD1, KLRK1, KRAS, LAT, LCK, LCP2, LOC652578, MAP2K1, MAP2K2, MAPK1, MAPK3, MICA, MICB, NCR1, NCR2, NCR3, NFAT5, NFATC1, NFATC2, NFATC3, NFATC4, NRAS, PAK1, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PLCG1, PLCG2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, PRF1, PRKCA, PRKCB1, PRKCG, PTK2B, PTPN11, PTPN6, RAC1, RAC2, RAC3, RAF1, SH2D1A, SH2D1B, SH3BP2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SYK, TNF, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFSF10, TYROBP, ULBP1, ULBP2, ULBP3, VAV1, VAV2, VAV3, ZAP70 | 122 | CASP3(1), GZMB(1), HLA-B(2), IFNA16(1), ITGB2(1), KIR3DL1(3), KLRK1(1), KRAS(9), MAPK1(1), MICB(1), NFATC4(1), NRAS(18), PIK3CB(1), PIK3R2(1), PLCG2(1), PPP3CA(1), PRKCG(1), PTK2B(1), PTPN11(7), SHC1(1), SOS1(1), SYK(1), VAV3(1), ZAP70(1) | 31625279 | 58 | 48 | 41 | 9 | 6 | 23 | 4 | 24 | 1 | 0 | <1.00e-15 | <3.85e-14 |
9 | GLUTATHIONE_METABOLISM | ANPEP, G6PD, GCLC, GCLM, GGT1, GPX1, GPX2, GPX3, GPX4, GPX5, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO2, GSTP1, GSTT1, GSTT2, GSTZ1, IDH1, IDH2, MGST1, MGST2, MGST3, PGD | 29 | G6PD(1), GCLM(1), GPX2(1), GSTM3(2), GSTT2(1), IDH1(20), IDH2(20), PGD(1) | 5222954 | 47 | 45 | 11 | 1 | 34 | 7 | 1 | 5 | 0 | 0 | <1.00e-15 | <3.85e-14 | |
10 | HSA04916_MELANOGENESIS | Genes involved in melanogenesis | ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, ASIP, CALM1, CALM2, CALM3, CALML3, CALML6, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CREB1, CREB3, CREB3L1, CREB3L2, CREB3L3, CREB3L4, CREBBP, CTNNB1, DCT, DVL1, DVL2, DVL3, EDN1, EDNRB, EP300, FZD1, FZD10, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, GNAI1, GNAI2, GNAI3, GNAO1, GNAQ, GNAS, GSK3B, HRAS, KIT, KITLG, KRAS, LEF1, LOC652788, MAP2K1, MAP2K2, MAPK1, MAPK3, MC1R, MITF, NRAS, PLCB1, PLCB2, PLCB3, PLCB4, POMC, PRKACA, PRKACB, PRKACG, PRKCA, PRKCB1, PRKCG, PRKX, PRKY, RAF1, TCF7, TCF7L1, TCF7L2, TYR, TYRP1, WNT1, WNT10A, WNT10B, WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B | 95 | ADCY2(1), ADCY3(1), ADCY4(2), ADCY5(1), CREB3L2(1), DCT(1), FZD1(1), GNAI2(1), KIT(8), KITLG(1), KRAS(9), MAPK1(1), NRAS(18), PLCB3(1), PRKCG(1), TCF7(1), TCF7L1(1), WNT11(2), WNT2B(1) | 29117083 | 53 | 44 | 34 | 3 | 7 | 18 | 3 | 23 | 2 | 0 | <1.00e-15 | <3.85e-14 |
rank | geneset | description | genes | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA04530_TIGHT_JUNCTION | Genes involved in tight junction | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, AMOTL1, ASH1L, CASK, CDC42, CDK4, CGN, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CRB3, CSDA, CSNK2A1, CSNK2A2, CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTTN, EPB41, EPB41L1, EPB41L2, EPB41L3, EXOC3, EXOC4, F11R, GNAI1, GNAI2, GNAI3, HCLS1, HRAS, IGSF5, INADL, JAM2, JAM3, KRAS, LLGL1, LLGL2, MAGI1, MAGI2, MAGI3, MLLT4, MPDZ, MPP5, MRAS, MRCL3, MRLC2, MYH1, MYH10, MYH11, MYH13, MYH14, MYH15, MYH2, MYH3, MYH4, MYH6, MYH7, MYH7B, MYH8, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NRAS, OCLN, PARD3, PARD6A, PARD6B, PARD6G, PPM1J, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R3A, PPP2R3B, PPP2R4, PRKCA, PRKCB1, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAB13, RAB3B, RHOA, RRAS, RRAS2, SPTAN1, SRC, SYMPK, TJAP1, TJP1, TJP2, TJP3, VAPA, YES1, ZAK | 124 | CDC42(1), CGN(1), CLDN11(1), CLDN16(1), CLDN18(1), CTNNA2(1), EXOC4(1), GNAI2(1), HCLS1(1), IGSF5(1), JAM2(1), LLGL2(1), MAGI1(1), MAGI2(1), MAGI3(1), MLLT4(2), MYH1(1), MYH13(2), MYH14(1), MYH15(1), MYH6(2), MYH7(2), MYL9(1), PARD3(1), PPP2R1B(1), PPP2R2B(1), PPP2R3A(1), PRKCG(1), TJAP1(3), TJP1(1), TJP2(1) | 54990864 | 37 | 31 | 36 | 13 | 12 | 6 | 4 | 10 | 5 | 0 | 0.000054 | 0.033 |
2 | ERBB3PATHWAY | Neuregulins bind to the receptor tyrosine kinases ErbB3 and ErbB4, surface-localized receptors whose overexpression induces tumor formation. | EGF, EGFR, ERBB3, NRG1, UBE2D1 | 5 | EGF(1), EGFR(2), ERBB3(2), UBE2D1(1) | 2995149 | 6 | 6 | 6 | 1 | 1 | 1 | 0 | 3 | 1 | 0 | 0.001 | 0.24 |
3 | HSA04510_FOCAL_ADHESION | Genes involved in focal adhesion | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BIRC4, BRAF, CAPN2, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL6A6, COMP, CRK, CRKL, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FIGF, FLNA, FLNB, FLNC, FLT1, FN1, FYN, GRB2, GRLF1, GSK3B, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAV, ITGB1, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC2, LAMC3, LOC653852, MAP2K1, MAPK1, MAPK10, MAPK3, MAPK8, MAPK9, MET, MLCK, MRCL3, MRLC2, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVA, PARVB, PARVG, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP5K1C, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PRKCA, PRKCB1, PRKCG, PTEN, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, ROCK1, ROCK2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SPP1, SRC, THBS1, THBS2, THBS3, THBS4, TLN1, TLN2, TNC, TNN, TNR, TNXB, VASP, VAV1, VAV2, VAV3, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, ZYX | 185 | ARHGAP5(1), CDC42(1), CHAD(1), COL11A2(1), COL1A1(1), COL2A1(2), COL3A1(1), COL4A6(1), COL5A3(1), DOCK1(1), EGF(1), EGFR(2), FLT1(1), FN1(2), ITGA10(1), ITGA11(1), ITGA4(1), ITGAV(1), KDR(2), LAMA1(2), LAMA2(1), LAMA3(2), LAMB3(1), LAMC2(1), LAMC3(1), MAPK1(1), MYL9(1), MYLK(1), MYLK2(1), PDGFRA(1), PDGFRB(1), PIK3CB(1), PIK3R2(1), PIP5K1C(1), PPP1R12A(1), PRKCG(1), RAP1B(1), RAPGEF1(1), SHC1(1), SOS1(1), THBS1(2), THBS3(1), TLN1(1), TNC(2), TNN(1), TNR(1), VASP(1), VAV3(1), VTN(1), VWF(3) | 103387067 | 60 | 39 | 60 | 20 | 17 | 12 | 9 | 17 | 5 | 0 | 0.0015 | 0.24 |
4 | HSA05130_PATHOGENIC_ESCHERICHIA_COLI_INFECTION_EHEC | Genes involved in pathogenic Escherichia coli infection - EHEC | ABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ | 51 | ABL1(2), CDC42(1), EZR(1), HCLS1(1), LY96(1), TLR4(1), TUBA1A(1), TUBA1B(1), TUBA3C(2), TUBB3(1), TUBB4(1), TUBB6(1), TUBB8(1), YWHAZ(1) | 15524189 | 16 | 16 | 16 | 6 | 4 | 3 | 2 | 6 | 1 | 0 | 0.002 | 0.24 |
5 | HSA05131_PATHOGENIC_ESCHERICHIA_COLI_INFECTION_EPEC | Genes involved in pathogenic Escherichia coli infection - EPEC | ABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ | 51 | ABL1(2), CDC42(1), EZR(1), HCLS1(1), LY96(1), TLR4(1), TUBA1A(1), TUBA1B(1), TUBA3C(2), TUBB3(1), TUBB4(1), TUBB6(1), TUBB8(1), YWHAZ(1) | 15524189 | 16 | 16 | 16 | 6 | 4 | 3 | 2 | 6 | 1 | 0 | 0.002 | 0.24 |
6 | HSA04810_REGULATION_OF_ACTIN_CYTOSKELETON | Genes involved in regulation of actin cytoskeleton | ABI2, ACTN1, ACTN2, ACTN3, ACTN4, APC, APC2, ARAF, ARHGEF1, ARHGEF12, ARHGEF4, ARHGEF6, ARHGEF7, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, C3orf10, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CRKL, CSK, CYFIP1, CYFIP2, DIAPH1, DIAPH2, DIAPH3, DOCK1, EGF, EGFR, EZR, F2, F2R, FGD1, FGD3, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GRLF1, GSN, HRAS, INS, IQGAP1, IQGAP2, IQGAP3, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, KRAS, LIMK1, LIMK2, LOC200025, LOC645126, LOC653888, MAP2K1, MAP2K2, MAPK1, MAPK3, MLCK, MOS, MRAS, MRCL3, MRLC2, MSN, MYH10, MYH14, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, NCKAP1, NCKAP1L, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PFN2, PFN3, PFN4, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5K3, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SCIN, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TIAM1, TIAM2, TMSB4X, TMSB4Y, TMSL3, VAV1, VAV2, VAV3, VCL, WAS, WASF1, WASF2, WASL | 191 | APC(4), ARHGEF1(1), ARHGEF6(1), BAIAP2(1), CDC42(1), DIAPH2(1), DOCK1(1), EGF(1), EGFR(2), EZR(1), FGF8(1), FN1(2), IQGAP3(3), ITGA10(1), ITGA11(1), ITGA4(1), ITGAD(2), ITGAV(1), ITGAX(1), ITGB2(1), MAPK1(1), MYH14(1), MYL9(1), MYLK(1), MYLK2(1), PDGFRA(1), PDGFRB(1), PIK3CB(1), PIK3R2(1), PIP5K1B(1), PIP5K1C(1), PPP1R12A(1), SOS1(1), SSH3(1), TIAM2(1), TMSL3(1), VAV3(1) | 77184737 | 45 | 33 | 45 | 10 | 13 | 9 | 6 | 13 | 4 | 0 | 0.0029 | 0.3 |
7 | CIRCADIAN_EXERCISE | ARNTL, AZIN1, BTG1, C10orf110, C1orf1, CBX3, CEBPB, CLDN5, CLOCK, CRY1, CRY2, DAZAP2, DAZAP2, LOC401029, DNAJA1, EIF4G2, ETV6, G0S2, GENX_3414, GFRA1, GSTM3, GSTP1, HERPUD1, HLA_DMA, HSPA8, IDI1, KLF9, MAP3K7IP2, MYF6, NCKAP1, NCOA4, NR1D2, OAZIN, PER1, PER2, PIGF, PPP1R3C, PPP2CB, PSMA4, PURA, SF3A3, SUMO3, TOB1, TUBB3, UCP3, UGP2, VAPA, ZFR | 36 | CRY1(1), DAZAP2(1), GSTM3(2), NR1D2(1), PIGF(1), PURA(1), TUBB3(1) | 10039948 | 8 | 8 | 8 | 2 | 0 | 0 | 3 | 3 | 2 | 0 | 0.0045 | 0.35 | |
8 | GLUTATHIONE_METABOLISM | ANPEP, G6PD, GCLC, GCLM, GGT1, GPX1, GPX2, GPX3, GPX4, GPX5, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO2, GSTP1, GSTT1, GSTT2, GSTZ1, IDH1, IDH2, MGST1, MGST2, MGST3, PGD | 27 | G6PD(1), GCLM(1), GPX2(1), GSTM3(2), GSTT2(1), PGD(1) | 4736200 | 7 | 7 | 7 | 1 | 0 | 4 | 1 | 2 | 0 | 0 | 0.0045 | 0.35 | |
9 | HSA04020_CALCIUM_SIGNALING_PATHWAY | Genes involved in calcium signaling pathway | ADCY1, ADCY2, ADCY3, ADCY4, ADCY7, ADCY8, ADCY9, ADORA2A, ADORA2B, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3, AGTR1, ATP2A1, ATP2A2, ATP2A3, ATP2B1, ATP2B2, ATP2B3, ATP2B4, AVPR1A, AVPR1B, BDKRB1, BDKRB2, BST1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CALM1, CALM2, CALM3, CALML3, CALML6, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, CCKAR, CCKBR, CD38, CHP, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA7, CYSLTR1, CYSLTR2, DRD1, EDNRA, EDNRB, EGFR, ERBB2, ERBB3, ERBB4, F2R, GNA11, GNA14, GNA15, GNAL, GNAQ, GNAS, GRIN1, GRIN2A, GRIN2C, GRIN2D, GRM1, GRM5, GRPR, HRH1, HRH2, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, ITPKA, ITPKB, ITPR1, ITPR2, ITPR3, LHCGR, LTB4R2, MLCK, MYLK, MYLK2, NOS1, NOS2A, NOS3, NTSR1, OXTR, P2RX1, P2RX2, P2RX3, P2RX4, P2RX5, P2RX7, P2RXL1, PDE1A, PDE1B, PDE1C, PDGFRA, PDGFRB, PHKA1, PHKA2, PHKB, PHKG1, PHKG2, PLCB1, PLCB2, PLCB3, PLCB4, PLCD1, PLCD3, PLCD4, PLCE1, PLCG1, PLCG2, PLCZ1, PLN, PPID, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, PRKACA, PRKACB, PRKACG, PRKCA, PRKCB1, PRKCG, PRKX, PRKY, PTAFR, PTGER1, PTGER3, PTGFR, PTK2B, RYR1, RYR2, RYR3, SLC25A4, SLC25A5, SLC25A6, SLC8A1, SLC8A2, SLC8A3, SPHK1, SPHK2, TACR1, TACR2, TACR3, TBXA2R, TNNC1, TNNC2, TRHR, TRPC1, VDAC1, VDAC2, VDAC3 | 163 | ADCY2(1), ADCY3(1), ADCY4(2), ADRA1A(1), ATP2A2(1), ATP2B2(1), ATP2B3(1), CACNA1B(3), CACNA1D(1), CACNA1E(3), CACNA1G(2), CACNA1I(1), CACNA1S(1), CAMK4(1), EGFR(2), ERBB3(2), GNA15(1), GRM5(1), HTR5A(1), ITPR1(1), ITPR3(1), MYLK(1), MYLK2(1), NOS1(1), P2RX7(1), PDGFRA(1), PDGFRB(1), PHKG1(1), PLCB3(1), PLCD4(1), PLCE1(4), PLCG2(1), PLCZ1(1), PPP3CA(1), PRKCG(1), PTK2B(1), RYR1(1), RYR3(4), TNNC2(1), TRPC1(1), VDAC1(1) | 76549927 | 55 | 39 | 55 | 21 | 14 | 12 | 7 | 20 | 2 | 0 | 0.0057 | 0.39 |
10 | CALCIUM_REGULATION_IN_CARDIAC_CELLS | ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3, ANXA6, ARRB1, ARRB2, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP2A2, ATP2A3, ATP2B1, ATP2B2, ATP2B3, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1S, CACNB1, CACNB3, CALM1, CALM2, CALM3, CALR, CAMK1, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, CASQ1, CASQ2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, FXYD2, GJA1, GJA12, GJA4, GJA5, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GNA11, GNAI2, GNAI3, GNAO1, GNAQ, GNAZ, GNB1, GNB2, GNB3, GNB4, GNB5, GNG12, GNG13, GNG2, GNG3, GNG4, GNG5, GNG7, GNGT1, GRK4, GRK5, GRK6, ITPR1, ITPR2, ITPR3, KCNB1, KCNJ3, KCNJ5, MGC11266, MYCBP, NME7, PEA15, PKIA, PKIB, PKIG, PLCB3, PLN, PRKACA, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB1, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ, PRKCZ, PRKD1, RGS1, RGS10, RGS11, RGS14, RGS16, RGS17, RGS18, RGS19, RGS2, RGS20, RGS3, RGS4, RGS5, RGS6, RGS7, RGS9, RYR1, RYR2, RYR3, SARA1, SFN, SLC8A1, SLC8A3, USP5, YWHAB, YWHAH, YWHAQ, YWHAQ, MIB1 | 135 | ADCY2(1), ADCY3(1), ADCY4(2), ADCY5(1), ADRA1A(1), ANXA6(1), ARRB1(1), ATP2A2(1), ATP2B2(1), ATP2B3(1), CACNA1B(3), CACNA1D(1), CACNA1E(3), CACNA1S(1), CACNB3(1), CALR(2), CAMK4(1), GJA4(1), GJB3(2), GJB4(1), GNAI2(1), GNB1(1), ITPR1(1), ITPR3(1), PKIB(1), PLCB3(1), PRKCG(1), RGS16(1), RGS3(1), RYR1(1), RYR3(4) | 54716642 | 41 | 30 | 41 | 16 | 11 | 11 | 3 | 12 | 4 | 0 | 0.0094 | 0.52 |
In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.